Form 4: ProAssurance Corp CFO Dana S. Hendricks Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Dana S. Hendricks, CFO of ProAssurance Corp, reports the acquisition of restricted stock units (RSUs) and grants power of attorney for SEC filings.

Summary

  • Dana S. Hendricks, Chief Financial Officer of ProAssurance Corp, filed a Form 4 on May 22, 2024, reporting changes in beneficial ownership of securities.
  • Hendricks acquired 23,058 Restricted Stock Units (RSUs) under the ProAssurance Corporation 2024 Equity Incentive Plan.
  • These RSUs will vest pro rata in increments equal to one-third of the total award in each of the years 2025, 2026 and 2027, contingent upon continuous employment.
  • Vesting accelerates upon termination of employment due to death, disability, or 'Good Reason'.
  • The RSUs will be settled in shares of ProAssurance Common Stock and in cash, with the cash portion covering taxes.
  • Hendricks also holds 7,961 RSUs from the 2014 Equity Incentive Compensation Plan, vesting pro rata in 2024, 2025, and 2026, and 9,084 RSUs from the same plan, vesting on December 31, 2024.
  • Hendricks granted power of attorney to several individuals to handle SEC filings related to Section 16(a) of the Securities Exchange Act of 1934.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing indicating standard executive compensation practices. It's neutral to slightly positive as it reflects alignment of management interests with shareholders.

Positives

  • The acquisition of RSUs aligns the CFO's interests with the long-term performance of ProAssurance.
  • The vesting schedule encourages continued employment and commitment to the company.
  • The power of attorney ensures timely and accurate SEC filings.

Future Outlook

The document outlines the vesting schedule for the acquired RSUs, indicating future equity compensation for the CFO contingent on continued employment and other conditions.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for aligning executive interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

  • Equity compensation is a standard practice among publicly traded companies to incentivize executives.
  • Vesting schedules of three to four years are common to ensure long-term commitment.
  • Companies like The Doctors Company and Medical Protective also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

  • Shareholders may view the RSU grant as a positive incentive for the CFO to drive long-term value.
  • Employees may see this as a standard compensation practice for executives.
  • The company's creditors and suppliers are unlikely to be directly impacted by this filing.

Key Dates

DateDescription
2019-05-22Date of Power of Attorney execution.
2024-05-22Date of transaction (acquisition of RSUs) and Form 4 filing.
2024-12-31Vesting date for 9,084 Restricted Share Units.
2025First vesting date for 2024 Equity Incentive Plan RSUs (one-third).
2026Second vesting date for 2024 Equity Incentive Plan RSUs (one-third) and final vesting date for 2014 Equity Incentive Compensation Plan RSUs (one-third).
2027Final vesting date for 2024 Equity Incentive Plan RSUs (one-third).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.